Zacks Research downgraded shares of M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY – Free Report) from a hold rating to a strong sell rating in a research report report published on Monday,Zacks reports.
M�nchener R�ckversicherungs-Gesellschaft Price Performance
Shares of OTCMKTS:MURGY opened at $12.33 on Monday. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.14 and a quick ratio of 1.14. M�nchener R�ckversicherungs-Gesellschaft has a 1-year low of $10.09 and a 1-year high of $13.68. The company has a market capitalization of $77.56 billion, a P/E ratio of 4.91, a P/E/G ratio of 2.18 and a beta of 0.36. The firm’s 50 day simple moving average is $11.81 and its two-hundred day simple moving average is $11.69.
M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY – Get Free Report) last announced its quarterly earnings data on Friday, August 7th. The financial services provider reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.11. The firm had revenue of $17.65 billion during the quarter, compared to analysts’ expectations of $18.75 billion. M�nchener R�ckversicherungs-Gesellschaft had a net margin of 11.49% and a return on equity of 20.81%. Research analysts expect that M�nchener R�ckversicherungs-Gesellschaft will post 1.19 EPS for the current fiscal year.
M�nchener R�ckversicherungs-Gesellschaft Company Profile
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, commonly known as Munich Re, is a Germany-based insurance group and one of the world’s major reinsurance providers. Through its reinsurance business, the company helps primary insurers manage and transfer risks arising from property damage, natural catastrophes, liability, accidents, life and health events, and other exposures.
Munich Re also provides specialty insurance and risk-management solutions, including coverage and services for corporate clients, infrastructure, cyber risks, and emerging technologies.
Further Reading
- Five stocks we like better than M�nchener R�ckversicherungs-Gesellschaft
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for M�nchener R�ckversicherungs-Gesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M�nchener R�ckversicherungs-Gesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
